↓ Skip to main content

A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target

Overview of attention for article published in Journal of Hematology & Oncology, September 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news
2 news outlets
twitter
2 X users

Citations

dimensions_citation
140 Dimensions

Readers on

mendeley
175 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target
Published in
Journal of Hematology & Oncology, September 2020
DOI 10.1186/s13045-020-00959-2
Pubmed ID
Authors

Andrea Ghelli Luserna di Rorà, Claudio Cerchione, Giovanni Martinelli, Giorgia Simonetti

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 175 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 175 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 25 14%
Student > Ph. D. Student 24 14%
Student > Bachelor 21 12%
Student > Master 17 10%
Student > Doctoral Student 7 4%
Other 17 10%
Unknown 64 37%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 50 29%
Medicine and Dentistry 16 9%
Agricultural and Biological Sciences 11 6%
Chemistry 6 3%
Pharmacology, Toxicology and Pharmaceutical Science 4 2%
Other 17 10%
Unknown 71 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 June 2023.
All research outputs
#2,029,942
of 25,483,400 outputs
Outputs from Journal of Hematology & Oncology
#163
of 1,295 outputs
Outputs of similar age
#53,771
of 430,633 outputs
Outputs of similar age from Journal of Hematology & Oncology
#9
of 35 outputs
Altmetric has tracked 25,483,400 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,295 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.5. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 430,633 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.